"Cachexia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Descriptor ID |
D002100
|
| MeSH Number(s) |
C23.888.144.243.963.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cachexia".
Below are MeSH descriptors whose meaning is more specific than "Cachexia".
This graph shows the total number of publications written about "Cachexia" by people in this website by year, and whether "Cachexia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 12 | 5 | 17 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cachexia" by people in Profiles.
-
Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management. J Cachexia Sarcopenia Muscle. 2021 04; 12(2):519-522.
-
Superior mesenteric artery syndrome in a patient with rheumatoid arthritis and rheumatoid cachexia during the COVID-19 pandemic. Clin Rheumatol. 2021 05; 40(5):2095-2096.
-
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers. J Cachexia Sarcopenia Muscle. 2021 02; 12(1):9-13.
-
Comment on 'COVID-19: a major cause of cachexia and sarcopenia' by Morley et al. J Cachexia Sarcopenia Muscle. 2021 02; 12(1):233-234.
-
December 2020 at a glance: focus on COVID-19, comorbidities and palliative care. Eur J Heart Fail. 2020 12; 22(12):2173-2174.
-
Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19. Med Hypotheses. 2021 Jan; 146:110434.
-
Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. Br J Nutr. 2021 Aug 28; 126(4):552-560.
-
Withaferin A: a potential therapeutic agent against COVID-19 infection. J Ovarian Res. 2020 Jul 19; 13(1):79.
-
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity. Int J Mol Sci. 2020 Jun 30; 21(13).
-
COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle. 2020 08; 11(4):863-865.